Joint recommendations for retinal screening in long‐term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018

Joint recommendations for retinal screening in long‐term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018

Hydroxychloroquine has become established in the management of various forms of cutaneous lupus, photosensitive dermatoses, porphyria cutanea tarda, cutaneous sarcoid, lichen planus and other inflammatory dermatological diseases.1 Dermatologists who prescribe hydroxychloroquine should be aware of ne...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Yusuf, IH, Lotery, AJ, Ardern-Jones, MR
Natura:	Journal article
Pubblicazione:	Wiley 2018

Documenti analoghi

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary
di: Yusuf, IH, et al.
Pubblicazione: (2018)

New recommendations for retinal monitoring in hydroxychloroquine users: Baseline testing is no longer supported
di: Yusuf, IH, et al.
Pubblicazione: (2021)

The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary
di: Yusuf, IH, et al.
Pubblicazione: (2021)

Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine
di: Lotery, A, et al.
Pubblicazione: (2018)

Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom
di: Yusuf, I, et al.
Pubblicazione: (2021)

Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
di: Yusuf, IH, et al.
Pubblicazione: (2018)

Immunomodulatory effects of hydroxychloroquine and chloroquine in viral infections and their potential application in retinal gene therapy
di: Chandler, L, et al.
Pubblicazione: (2020)

Chloroquine, hydroxychloroquine and COVID-19
di: Erickson, T. B., et al.
Pubblicazione: (2020)

The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom
di: Yusuf, IH, et al.
Pubblicazione: (2024)

Hydroxychloroquine hitting the headlines: Retinal considerations
di: Downes, SM, et al.
Pubblicazione: (2020)

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
di: Gbinigie, O, et al.
Pubblicazione: (2020)

Hydroxychloroquine retinopathy.
di: Yusuf, I, et al.
Pubblicazione: (2017)

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
di: White, NJ, et al.
Pubblicazione: (2020)

An audit of the use of hydroxychloroquine in rheumatology clinics
di: Worth, C, et al.
Pubblicazione: (2018)

A nationwide survey of hydroxychloroquine retinopathy presenting to the hospital eye service in the United Kingdom
di: Yusuf, IY, et al.
Pubblicazione: (2022)

Hydroxychloroquine and Chloroquine Toxicity as Reported by Medical Toxicologists to the Toxicology Investigators Consortium (ToxIC) Registry
di: Griswold, Matthew K., et al.
Pubblicazione: (2022)

Hydroxychloroquine and Chloroquine Toxicity as Reported by Medical Toxicologists to the Toxicology Investigators Consortium (ToxIC) Registry
di: Griswold, Matthew K., et al.
Pubblicazione: (2022)

Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine
di: Whittaker, DG, et al.
Pubblicazione: (2021)

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
di: Axfors, C, et al.
Pubblicazione: (2021)

Thinking outside the circle—the potential value of ultra-widefield imaging
di: Yusuf, IH, et al.
Pubblicazione: (2022)

Hydroxychloroquine retinopathy: an emerging problem.
di: Latasiewicz, M, et al.
Pubblicazione: (2017)

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
di: Schilling, WHK, et al.
Pubblicazione: (2024)

Novel imaging techniques for hydroxychloroquine retinopathy
di: Yusuf, I, et al.
Pubblicazione: (2022)

Developing gene therapy for inherited retinal degenerations
di: Yusuf, IH
Pubblicazione: (2022)

Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)
di: Schilling, WHK, et al.
Pubblicazione: (2020)

Pentosan Polysulfate Maculopathy—Prescribers Should Be Aware
di: Yusuf, IH, et al.
Pubblicazione: (2020)

Diagnosis of inherited retinal diseases
di: Birtel, J, et al.
Pubblicazione: (2021)

Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations.
di: White, N, et al.
Pubblicazione: (1988)

Hydroxychloroquine in hospitalized patients with Covid-19. Reply
di: Horby, P, et al.
Pubblicazione: (2021)

Hydroxychloroquine for COVID-19: Balancing contrasting claims
di: Horby, PW, et al.
Pubblicazione: (2020)

Effect of hydroxychloroquine in hospitalized patients with COVID-19
di: Horby, P, et al.
Pubblicazione: (2020)

Changes in retinal sensitivity associated with cotoretigene toliparvovec in X-linked retinitis pigmentosa with RPGR gene variations
di: von Krusenstiern, L, et al.
Pubblicazione: (2023)

Failure of chloroquine-erythromycin and chloroquine-tetracycline combinations in treatment of chloroquine-resistant falciparum malaria in eastern Thailand.
di: Phillips, R, et al.
Pubblicazione: (1984)

Epidemiology of giant retinal tears in the United Kingdom: the British Giant Retinal Tear Epidemiology Eye Study (BGEES).
di: Ang, G, et al.
Pubblicazione: (2010)

Effect of antiretroviral therapy on plasma concentrations of chloroquine and desethyl-chloroquine
di: Ippolito, M, et al.
Pubblicazione: (2018)

Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
di: Baird, J, et al.
Pubblicazione: (1995)

Effect of hydroxychloroquine in hospitalized patients with COVID-19 - preliminary report
di: Linsell, L, et al.
Pubblicazione: (2020)

Electrophysiological and proarrhythmic effects of hydroxychloroquine challenge in guinea-pig hearts
di: Wang, G, et al.
Pubblicazione: (2021)

Retinitis pigmentosa caused by variants in SNRNP200
di: Yusuf, IH, et al.
Pubblicazione: (2019)

Plasma chloroquine concentrations in young and older malaria patients treated with chloroquine.
di: Maitland, K, et al.
Pubblicazione: (1997)